Counterpoint Mutual Funds’s NEVRO CORP. NVRO Stock Holding History

Counterpoint Mutual Funds’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,844	Closed	-$132K	–	316
2023 Q3	$132K	Buy	+6,844	New	+$146K	0.11%	112

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Counterpoint Mutual Funds's NVRO Position: Q4 2023 in Review

Counterpoint Mutual Funds sold out of NEVRO CORP. (NVRO) in Q4 2023, closing a stake of 6,844 shares — an estimated $132K sold.

Counterpoint Mutual Funds first reported a position in NVRO in Q3 2023 and held it in 1 quarter. The position peaked at $132K in Q3 2023. 140 funds tracked by Wall St. Rank hold NVRO as of Q4 2023.

Counterpoint Mutual Funds reported no remaining NEVRO CORP. position as of Q4 2023 after selling out during the quarter.
Counterpoint Mutual Funds sold 6,844 NEVRO CORP. shares in Q4 2023, an estimated $132K.
Counterpoint Mutual Funds first reported a position in NEVRO CORP. in Q3 2023 and held it in 1 quarter.
Counterpoint Mutual Funds's NEVRO CORP. position peaked at $132K in Q3 2023.
140 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2023.

Based on Counterpoint Mutual Funds's 13F filing for Q4 2023, filed 7 Feb 2024.